Dementia research networks and studies
Academic and industry scientists bring expertise to DPUK's dementia research networks and studies.
FIND OUT ABOUT SCIENTISTS IN DPUK'S DEMENTIA RESEARCH NETWORKS AND STUDIES
DPUK's technology networks link research institutions across the UK with state-of-the-art infrastructure, supporting a new generation of multicentre experimental medicine studies for dementia. There are three technology networks.
Scientists across the UK are working together in DPUK's dementia research networks and studies
The Data Portal helps researchers access and analyse longitudinal cohort data, including complex imaging and genetic data. It was developed by researchers in DPUK's informatics network.
Seven research universities – Edinburgh, Newcastle, Manchester, Cambridge, Imperial College London, UCL, and King's College London – make up the world's first national imaging network.
At each site, a state-of-the-art PET-MR scanner allows imaging scientists to conduct dementia studies using the the latest PET-MR techniques. Each of the scanners is being calibrated to the same precise standards, so researchers will be able to plan and run UK-wide brain imaging studies involving more than one scanner. What's more, experts in each of these institutions are benefiting from advanced training and skills development.
Thanks to the networked technology and expertise, scientists are able to conduct much more ambitious dementia research.
Stem cells network
The stem cells network supports researchers who are working on cellular reprogramming, cellular phenotyping, neuronal physiology and iPSC stem cell lines. The network is allowing scientists to benefit from highly developed specialist techniques in each laboratory and to share their resources. For example, iPSC cells first developed in Edinburgh are being used in experiments in Oxford. Stem cell researchers can apply to access this resource here.
CONNECT WITH SCIENTISTS IN YOUR FIELD
When scientists from universities and industry join forces in networked teams, the result is collaborations, ambitious ideas and and new large-scale dementia studies.